Whole-body distribution and radiation dosimetry of 68Ga-NOTA- RGD, a positron emission tomography agent for angiogenesis imaging

Cancer Biotherapy and Radiopharmaceuticals

Volumn 27, Issue 1, 2012, Pages 65-71

  Kim, Joong Hyun ^a   Lee, Jae Sung ^a   Kang, Keon Wook ^a   Lee, Ho Young ^a   Han, Sae Won ^a   Kim, Tae You ^a   Lee, Yun Sang ^a   Jeong, Jae Min ^a   Lee, Dong Soo ^a  

^a Seoul National University College of Medicine   (South Korea)

Author keywords

angiogenesis; biodistribution; dosimetry; PET; RGD

Indexed keywords

1,4,7 TRIAZACYCLONONANE 1,4,7 TRIACETIC ACID; ACETIC ACID DERIVATIVE; ARGINYLGLYCYLASPARTIC ACID; GALLIUM 1,4,7 TRIAZACYCLONONANE 1,4,7 TRIACETIC ACID ARGINYLGLYCYLASPARTIC ACID GA 68; GALLIUM 68; TRACER; UNCLASSIFIED DRUG;

ADULT; AGED; ANGIOGENESIS; ARTICLE; BLADDER; CLINICAL ARTICLE; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DOSIMETRY; FEMALE; GALLBLADDER; HEART; HUMAN; KIDNEY; LIVER; LUNG; LUNG CANCER; LYMPHOMA; MALE; PANCREAS; PRIORITY JOURNAL; RADIATION DOSE DISTRIBUTION; SPLEEN; STOMACH; WHOLE BODY PET;

ADULT; AGED; FEMALE; GALLIUM RADIOISOTOPES; HETEROCYCLIC COMPOUNDS; HUMANS; LUNG NEOPLASMS; LYMPHOMA; MALE; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; OLIGOPEPTIDES; POSITRON-EMISSION TOMOGRAPHY; RADIATION DOSAGE; RADIOMETRY; RADIOPHARMACEUTICALS; TISSUE DISTRIBUTION;

EID: 84863116379     PISSN: 10849785     EISSN: 15578852     Source Type: Journal    
DOI: 10.1089/cbr.2011.1061     Document Type: Article

References (34)

1. Veikkola T, Karkkainen M, Claesson-Welsh L, et al. Regulation of angiogenesis via vascular endothelial growth factor receptors. Cancer Res 2000;60:203.
2. Carmeliet P. Angiogenesis in life, disease and medicine. Nature 2005;438:932.
3. Ferrara N, Kerbel RS. Angiogenesis as a therapeutic target. Nature 2005;438:967.
4. Guo W, Giancotti FG. Integrin signalling during tumour progression. Nat Rev Mol Cell Biol 2004;5:816.
5. Brooks PC, Montgomery AM, Rosenfeld M, et al. Integrin avb3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels. Cell 1994;79:1157.
6. Hood JD, Cheresh DA. Role of integrins in cell invasion and migration. Nat Rev Cancer 2002;2:91.
7. Ruoslahti E. Specialization of tumour vasculature. Nat Rev Cancer 2002;2:83.
8. Haubner R, Beer AJ, Wang H, et al. Positron emission tomography tracers for imaging angiogenesis. Eur J Nucl Med Mol Imaging 2010;37(Suppl):S86.
9. Yang J, Guo H, Miao Y. Technetium-99m-labeled Arg-Gly- Asp-conjugated alpha-melanocyte stimulating hormone hybrid peptides for human melanoma imaging. Nucl Med Biol 2010;37:873.
10. Yan Y, Chen K, Yang M, et al. A new 18F-labeled BBN-RGD peptide heterodimer with a symmetric linker for prostate cancer imaging. Amino Acids 2011;41:439.
11. Picchio M, Beck R, Haubner R, et al. Intratumoral spatial distribution of hypoxia and angiogenesis assessed by 18FFAZA and 125I-Gluco-RGD autoradiography. J Nucl Med 2008;49:597.
12. Liu Z, Yan Y, Liu S, et al. 18F, 64Cu, and 68Ga labeled RGDbombesin heterodimeric peptides for PET imaging of breast cancer. Bioconjug Chem 2009;20:1016.
13. Yoshimoto M, Ogawa K, Washiyama K, et al. avb3 Integrintargeting radionuclide therapy and imaging with monomeric RGD peptide. Int J Cancer 2008;123:709.
14. Beer AJ, Haubner R, Wolf I, et al. PET-based human dosimetry of 18F-galacto-RGD, a new radiotracer for imaging avb3 expression. J Nucl Med 2006;47:763.
15. McParland BJ, Miller MP, Spinks TJ, et al. The biodistribution and radiation dosimetry of the Arg-Gly-Asp peptide 18F-AH111585 in healthy volunteers. J Nucl Med 2008;49: 1664.
16. Jeong JM, Hong MK, Chang YS, et al. Preparation of a promising angiogenesis PET imaging agent: 68Ga-labeled c(RGDyK)-isothiocyanatobenzyl-1,4, 7-triazacyclononane- 1,4,7-triacetic acid and feasibility studies in mice. J Nucl Med 2008;49:830.
17. Breeman WA, Verbruggen AM. The 68Ge/68Ga generator has high potential, but when can we use 68Ga-labelled tracers in clinical routine? Eur J Nucl Med Mol Imaging 2007;34:978.
18. Shetty D, Lee YS, Jeong JM. 68Ga-labeled radiopharmaceuticals for positron emission tomography. Nucl Med Mol Imaging 2010;44:233.
19. Ehrhardt GJ, Welch MJ. A new germanium-68/gallium-68 generator. J Nucl Med 1978;19:925.
20. Kolbert KS, Pentlow KS, Pearson JR, et al. Prediction of absorbed dose to normal organs in thyroid cancer patients treated with 131I by use of 124I PET and 3-dimensional internal dosimetry software. J Nucl Med 2007;48:143.
21. Antenor-Dorsey JA, Laforest R, Moerlein SM, et al. Radiation dosimetry of N-([11C]methyl)benperidol as determined by whole-body PET imaging of primates. Eur J Nucl Med Mol Imaging 2008;35:771.
22. Stabin MG, Sparks RB, Crowe E. OLINDA/EXM: The second-generation personal computer software for internal dose assessment in nuclear medicine. J Nucl Med 2005;46: 1023.
23. Treyer V, Streffer J, Ametamey SM, et al. Radiation dosimetry and biodistribution of 11C-ABP688 measured in healthy volunteers. Eur J Nucl Med Mol Imaging 2008; 35:766.
24. Nye JA, Schuster DM, Yu W, et al. Biodistribution and radiation dosimetry of the synthetic nonmetabolized amino acid analogue anti-18F-FACBC in humans. J Nucl Med 2007;48:1017.
25. Thomas SR, Stabin MG, Chen CT, et al. MIRD Pamphlet No. 14 revised: A dynamic urinary bladder model for radiation dose calculations. J Nucl Med 1999;40:102S.
26. Hirvonen J, Roivainen A, Virta J, et al. Human biodistribution and radiation dosimetry of 11C-(R)-PK11195, the prototypic PET ligand to image inflammation. Eur J Nucl Med Mol Imaging 2010;37:606.
27. Hartmann H, Zö phel K, Freudenberg R, et al. Radiation exposure of patients during 68Ga-DOTATOC PET/CT examinations. Nuklearmedizin 2009;48:201.
28. Pettinato C, Sarnelli A, Di Donna M, et al. 68Ga-DOTANOC: Biodistribution and dosimetry in patients affected by neuroendocrine tumors. Eur J Nucl Med Mol Imaging 2008; 35:72.
29. Scheinin NM, Tolvanen TK, Wilson IA, et al. Biodistribution and radiation dosimetry of the amyloid imaging agent 11CPIB in humans. J Nucl Med 2007;48:128.
30. Seltzer MA, Jahan SA, Sparks R, et al. Radiation dose estimates in humans for 11C-acetate whole-body PET. J Nucl Med 2004;45:1233.
31. Slifstein M, Hwang DR, Martinez D, et al. Biodistribution and radiation dosimetry of the dopamine D2 ligand 11C-raclopride determined from human whole-body PET. J Nucl Med 2006;47:313.
32. Leide-Svegborn S. Radiation exposure of patients and personnel from a PET/CT procedure with 18F-FDG. Radiat Prot Dosimetry 2010;139:208.
33. Lin KJ, Weng YH, Wey SP, et al. Whole-body biodistribution and radiation dosimetry of 18F-FP-( + )-DTBZ (18F-AV-133): A novel vesicular monoamine transporter 2 imaging agent. J Nucl Med 2010;51:1480.
34. Koole M, Lewis DM, Buckley C, et al. Whole-body biodistribution and radiation dosimetry of 18F-GE067: A radioligand for in vivo brain amyloid imaging. J Nucl Med 2009;50:818.